Biocon Biologics Ltd, a subsidiary of Biocon Ltd, announced new dermatology data at the European Academy of Dermatology and Venereology (EADV) 2024 Congress...
In a late-stage trial, patients receiving Tremfya were able to achieve endoscopic remission a state where no signs of inflammation, ulcers or bleeding...
